Stay updated on Inetetamab Plus Rapamycin for HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Inetetamab Plus Rapamycin for HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Inetetamab Plus Rapamycin for HER2+ Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The new screenshot shows an updated submission date in the Study Record Versions section for NCT04736589, while the rest of the page content remains the same. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-02T07:20:57.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    Added a government operating-status notice and updated version to v3.2.0; removed the previous v3.1.0 tag.
    Difference
    13%
    Check dated 2025-10-04T16:55:16.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Version tag updated from v3.0.2 to v3.1.0, indicating an updated release.
    Difference
    0.3%
    Check dated 2025-09-27T10:59:40.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2; no other content changes detected.
    Difference
    0.3%
    Check dated 2025-09-13T02:07:24.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.3%
    Check dated 2025-09-05T20:02:29.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, while several location-related terms and details have been removed.
    Difference
    4%
    Check dated 2025-08-29T19:01:12.000Z thumbnail image

Stay in the know with updates to Inetetamab Plus Rapamycin for HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Inetetamab Plus Rapamycin for HER2+ Breast Cancer Clinical Trial page.